Proteome Sciences plc (AIM:PRM) received notification from Vulpes Life Sciences Fund ('Vulpes'), of which Martin Diggle, a non-executive director of the Company, is a director and partner, that today, it purchased 105,590 ordinary shares of 1 pence each ('Ordinary Shares') at 5.5 pence per Ordinary Share (the 'Transaction'). Following the Transaction, Vulpes (and Mr Diggle) have a beneficial interest in 53,943,715 Ordinary Shares, representing approximately 18.33% of the current issued share capital of the Company.

Proteome Sciences plc published this content on 05 January 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 05 January 2017 16:12:03 UTC.

Original documenthttp://www.proteomics.com/news/post/holdings-in-company-and-pdmr-shareholding-2

Public permalinkhttp://www.publicnow.com/view/D92172C8C12221975F37D15D363524835777CD09